id
type
5 (blog/news article)
status
21 (imported old-v2, waiting for another import)
review version
0
cleanup version
0
pending deletion
0 (-)
created at
2025-12-31 03:55:44
updated at
2025-12-31 03:55:44
pol page id
pol status
0
pol hosts ticketing
pol hosts ecommerce
pol hosts finance
pol hosts crypto
pol hosts leak
pol hosts devel
pol hosts ugc
linkedin.com
pol hosts klim
pol hosts builders
pol hosts self subdomains
pol hosts other subdomains
cdn.sanity.io
pol hosts other domains
prnewswire.com alpheusmedical.com
pol updated
1767349674
url
https://acsbrightedge.org/news/fda-grants-alpheus-medical-orphan-drug-and-fast-track-designations-for-novel-sonodynamic-therapy-for-brain-cancer/
url length
145
url crc
10831
url crc32
622733903
location type
1 (url matches target location, page_location is empty)
canonical status
2 (missing canonical tag in html)
canonical page id
-
domain id
domain tld
2688
domain parts
2
originating warc id
13193312
originating url
source type
11 (CommonCrawl)
server ip
Publication date
2025-08-02 23:53:36
Fetch attempts
0
Original html size
124056
Normalized and saved size
17405
title
excerpt
content
Portfolio NewsFDA Grants Alpheus Medical Orphan Drug and Fast Track Designations for Novel Sonodynamic Therapy for Brain CancerJuly 2024The company is currently enrolling patients in a multi-center Phase 1 clinical trial for the treatment of recurrent glioblastoma (GBM)See original press release here.OAKDALE, Minn., July 13, 2022 /PRNewswire/ - Alpheus™ Medical, Inc, a privately held company developing a novel sonodynamic therapy (SDT) platform targeting solid body cancers, today announced the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug and Fast Track Designations to Alpheus Medical's CV-01 delivery of sonodynamic therapy (SDT) as a potential treatment for patients with recurrent glioblastoma, the most common primary brain cancer, and other malignant gliomas. Northwell Health's North Shore University Hospital in Long Island, New York, is currently enrolling patients in the multi-center Phase 1 clinical trial. The First-in-Human trial will evaluate the safety, o...
author
updated
1767349674
block type
0
extracted fields
96
extracted bits
full content
content was extracted heuristically
detected location
0
detected language
1 (English)
category id
-
index version
1
paywall score
0
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
3148
text words
550
text unique words
262
text lines
1
text sentences
17
text paragraphs
1
text words per sentence
32
text matched phrases
0
text matched dictionaries
0
links self subdomains
0
links other subdomains
1
links other domains
3
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
1
links ext klim
0
links ext generic
0
image author
featured image